J&J shares slide after company says COVID-19 vaccine is 72% effective in US, 66% overall

Johnson & Johnson on Friday said its single-shot coronavirus vaccine was 72% effective in preventing moderate to severe COVID-19 in the U.S, but fell to 66% in a larger trial conducted worldwide.

For more news, please go to FoxBusiness.com and watch Fox Business Network.

More NewslettersUnsubscribePrivacy PolicyContact Us

©2021 Fox News Network, LLC. 1211 Avenue of the Americas, New York, NY, 10036. All Rights Reserved. Privacy Policy

Fox Business never sends unsolicited email. You received this email because you requested a subscription to Fox Business Breaking News Alerts from FoxBusiness.com